COVID-19 in Chronic Liver Disease and Liver Transplantation
- 24 December 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 55 (3) , 187-194
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has led to over 150,000 deaths in the United States and over 660,000 deaths around the world. Mounting evidence suggests that chronic liver diseases can have an adverse effect on the clinical outcomes of patients with COVID-19. We present a comprehensive review of the latest literature on preexisting liver diseases and its interrelationship with COVID-19 infection in cirrhosis, hepatocellular carcinoma, nonalcoholic fatty liver disease, autoimmune hepatitis, and viral hepatitis B. As social distancing and telemedicine gain new footing, we synthesize recommendations from 3 major hepatology societies [American Association for the Study of Liver Disease (AASLD), the European Association for the Study of Liver (EASL), and the Asian Pacific Association for the Study of Liver (APASL)] to present the best approaches for caring for patients with liver diseases as well as those requiring liver transplantation.Keywords
This publication has 63 references indexed in Scilit:
- Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposureJournal of Hepatology, 2020
- Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolismJHEP Reports, 2019
- Cholangiocyte pathobiologyNature Reviews Gastroenterology & Hepatology, 2019
- Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observationInternational Journal of Rheumatic Diseases, 2017
- Epidemiology and Natural History of Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2015
- American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug TherapyGastroenterology, 2015
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology, 2014
- Pulmonary complications in chronic liver diseaseHepatology, 2014
- Acute Respiratory Failure Complicating Advanced Liver DiseaseSeminars in Respiratory and Critical Care Medicine, 2012
- Immune Dysfunction and Infections in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2011